EMT is a critical facilitator of tumor metastasis and is characterized by upregulated expression of mesenchymal markers (e.g., N-cadherin, vimentin) and downregulated expression of epithelial markers (e.g., E-cadherin) [26]. The gene discussed is CDH1; the disease is neoplasm.